TrialFrontiers in endocrinology2024
Serum exocrine pancreas enzymes are biomarkers of immunotherapy response in new-onset type 1 diabetes.
Brittany Sorensen Bruggeman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it